RAMPART IC adds Dr. Eric Secemsky to its Medical Advisory Board
BIRMINGHAM, AL - RAMPART IC is pleased to announce that renowned interventional cardiologist Eric A. Secemsky M.D. will join the company’s growing Medical Advisory Board to help guide Rampart’s mission to offer better radiation protection solutions for teams providing care in interventional suites. Dr. Secemsky MSc, RPVI, FACC, FAHA, FSCAI, FSVM is currently Director of Vascular Intervention and interventional cardiologist at Beth Israel Deaconess Medical Center.
I want to ensure the next generation of interventional teams experience a safer and more comfortable work environment, so they can be active and enjoy life outside the interventional suite,” he said.
- Dr. Eric Secemsky
Dr. Secemsky is passionate about maintaining the well-being of not only his patients, but his colleagues and staff who perform interventional procedures while being exposed to the risks of ionizing radiation and the effects of wearing heavy lead aprons.
Rampart Founder and Chief Medical Officer Dr. Bob Foster, said the company is pleased to add Dr. Secemsky and his expertise in vascular intervention, interventional cardiology, clinical research. “As we innovate and expand the reach of our solutions to other therapies, Dr. Secemsky’s experience and passion will be instrumental in enabling access to Rampart’s solutions for all interventional teams around the world,” he explained.
Deciding to serve on Rampart’s medical board was an easy commitment for the already very busy Dr. Secemsky. “I’m honored to join the Rampart Medical Advisory Board. Radiation safety and orthopedic protection are a passion of mine. Performing countless complex procedures over the years has shown me first-hand the risks of ionizing radiation and the orthopedic damage from wearing heavy lead aprons. I want to ensure the next generation of interventional teams experience a safer and more comfortable work environment, so they can be active and enjoy life outside the interventional suite,” he said.
Dr. Secemsky joins Drs. Rhian Davies, Bill Lombardi, Bill Nicholson, Steve Steuterman, Didier TcheTche, and Prof. James Spratt on Rampart's Medical Advisory Board.
Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab and the inpatient and outpatient vascular medicine services. Dr. Secemsky leads the interventional cardiology and vascular research program at the Smith Center for Outcomes Research in Cardiology.
He is an Associate Editor at Vascular Medicine and is on the Editorial Boards at Circulation: Cardiovascular Interventions and JSCAI. He is also the current Chair of the PERT Consortium Research Committee, is a writing member of the 2022 ACC/AHA Guideline on the Management of Lower Extremity Peripheral Artery Disease (PAD), and is on the Board of Directors for the VIVA Foundation and the Society for Vascular Medicine.
Rampart CEO Tom Livingston said the company is privileged to have Dr. Secemsky join the Medical Advisory Board. “Eric brings a depth of experience, incredible reputation, and a tremendously powerful mind to our team,” he said. “More importantly, Eric also has a heart for protecting the healthcare provider in the cath lab. We look forward to being on this mission with Eric.”
RAMPART IC, LLC is a Birmingham, Alabama based medical device company whose radiation shielding solutions provide team protection in the cath lab without the need for traditional lead aprons, which can cause orthopedic issues for some team members. Available directly and through distribution partnerships, Rampart’s solutions are implemented in cath labs and other interventional suites worldwide